skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

疫学予測、プライマリー調査による医療用医薬品の市場調査レポートライブラリー

Datamonitor Healthcare

Datamonitor Healthcare(データモニターヘルスケア)では、欧米に拠点を置くインフォーマのアナリストによる医療用医薬品の市場調査レポートを収録しています。各市場調査レポートは米国、欧州5か国(イギリス、フランス、ドイツ、イタリア、スペイン)、日本の計7つの医薬品市場を中心に、各疾患市場について下記の項目を網羅しています。疫学情報、治療実態、売上予測に関してはエクセルファイルでデータパックのダウンロードも可能です。

  • 薬剤の売上予測(患者数ベース)
  • 各市場の疾患別治療実態
  • 疫学情報(アナリストとは異なる専門の疫学者(エピデミオロジスト(チームが担当。米国、欧州5か国、日本に加えその他38か国が対象)
  • 臨床および商業的観点からの上市済み医薬品と開発パイプラインの製品評価
  • 価格・償還制度

 

Datamonitor Healthcareでは下記項目を分析して患者ベースの売上予測を算出します。

  • 疫学者(エピデミオロジスト)チームによる患者セグメントの特定
  • 1疾患当たり7か国210名以上の専門医へのプライマリーリサーチ(アンケート調査によるKOLインタビュー)により治療アルゴリズムを特定
  • インフォーマのアナリストの見解を提示
    • 企業(財務、薬剤評価・比較、SWOT分析、成功確率に影響を与えるイベント分析)
    • 価格・償還(薬価下げ圧力、後発医薬品参入の影響)
    • 戦略(ヘルスケア業界全体のトレンド、医薬品市場の現状と課題)

     

Datamonitor Healthcareの活用事例などさらに詳しい説明を兼ねたデモンストレーションをご希望の場合は下記よりお申し込み下さい。

また、開発中の医療用医薬品の承認に影響を与えるイベントをリアルタイムで追跡し、アメリカ食品医薬品局(FDA)の承認確率(LOA: Likelihood of Approval)で示す姉妹サービスBiomedtracker(バイオメドトラッカー)を合わせて利用されるとより効果的です。

その他ご質問などございましたらお問い合わせフォームよりお気軽にご連絡ください。

このサービスの特徴

無料の最新記事&レポート

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Gene Therapy: A Paradigm Shift in Medicine

    30 Nov 2018

    The following analysis reviews several aspects of the gene therapy market. The history of gene therapy is briefly discussed, alongside a look at the trend in the volume of candidates in development over the past 20+ years, and how the regulatory landscape in the US and EU has recently adapted to help move the field forward. A deep dive into the pipeline with  breakdowns by delivery method and therapy area is provided, as are the key companies involved and the major partnership deals that have made gene therapy a hot commodity. Manufacturing, pricing, and reimbursement issues are also addressed.

    Topic cell-and-gene-therapy

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    December 2018 National Influenza Week

    29 Nov 2018

    3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

    Topic influenza-virus infectious-diseases

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    World AIDS Day 2018 GlaxoSmithKline report

    29 Nov 2018

    PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

    Topic diseases drug-development-landscape drug-review

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Depression Disease Market and Forecast Analysis 2024

    24 Oct 2018

    Informa Pharma Intelligence is marking Depression Awareness Month with a free download of Depression Disease Market and Forecast Analysis 2024. Download your free extract from this vital report and tap into the exclusive data and insights into the depression market available only from the experts at Datamonitor Healthcare, part of the Informa Pharma Intelligence suite of tools.

    Topic drug-development-landscape

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Better Heart Health Whitepaper

    22 Oct 2018

    In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.

  • Datamonitor Healthcare

    Neuropathic Pain Market and Forecast Analysis to 2026

    07 Sep 2018

    Big changes are coming to the neuropathic pain market – are you prepared? Take a look at the projected neuropathic pain drug sales for the US, Japan, and five EU nations with the latest infographic from Datamonitor Healthcare. This snapshot view of the future of the neuropathic pain market is packed with data from the full Datamonitor Healthcare Neuropathic Pain Disease Coverage report.

  • Datamonitor Healthcare

    Meningococcal Vaccines Forecast Infographic

    28 Aug 2018

    Over 1.2 million cases of bacterial meningitis are estimated to occur worldwide each year. If not treated promptly, up to half of those cases will be fatal. This infographic from Datamonitor Healthcare provides a snapshot of the meningococcal vaccines market in the US and five major EU markets. What does the meningococcal vaccines market have in store and how will it affect your business? Download now.

    Topic vaccines

  • Datamonitor Healthcare

    Epidiolex and Epilepsy - big changes for medical marijuana

    28 Aug 2018

    With the FDA’s landmark approval of Epidiolex, a cannabidiol used to treat rare, severe pediatric epilepsies, the only obstacle to the legal sale of the drug is DEA reclassification of cannabidiol (CBD). With reclassification likely in the next 90 days, what does it mean for the epilepsy market, as well as the wider market for CBD?

    Topic Drug approval

  • Datamonitor Healthcare

    Japan Pharma Outlook 2027 Report Extract

    27 Aug 2018

    Download your complimentary Japan Pharma Outlook 2027 report extract. The 16-page excerpt includes highlights from the full report, which is available to subscribers of Datamonitor Healthcare, and available to purchase on our Report Store. Discover now the complex challenges and opportunities facing Japan Pharma.

  • Datamonitor Healthcare

    Trends in Gene Therapy Seminar

    By Patricia Reilly 22 Aug 2018

    The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.

  • Datamonitor Healthcare

    Podcast - Analyst Opinion on Approval of AndexXa for reversal of Eliquis and Xarelto

    By Zachary McLellan 22 Aug 2018

    Zach McLellan, Jack Allen, and guest analyst Cameron Findlater discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of AndexXa for reversal of Eliquis and Xarelto & Eli Lilly's acquisition of ARMO Biosciences.

  • Datamonitor Healthcare

    Japan Pharma Outlook Webinar Recording

    By Ian Haydock 22 Aug 2018

    Listen to this insightful presentation of the unique challenges and opportunities faced by Japan Pharma, hosted by the expert analysts from Pharma Intelligence.

    Topic drug-development-landscape

  • Datamonitor Healthcare

    Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 2

    22 Aug 2018

    Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

    Topic Cancer

  • Datamonitor Healthcare

    Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 1

    By Jack Allen 22 Aug 2018

    Zach McLellan and Jack Allen are joined by guest analysts Dominique Fontanilla and Hardik Patel. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

    Topic cancer

  • Datamonitor Healthcare

    Business Development and Licensing Video

    01 Jul 2018

    If you’re a senior business development and licensing professional in pharma or biotech, it’s your job to ensure that your company’s revenue pipeline is full of viable opportunities and accelerate growth for your organisation. Watch this short video  and discover how Informa’s Pharma Intelligence provides the rock-solid intelligence you need to accelerate growth and drive business forward.

    Topic business-strategies

医薬品産業専門のジャーナリスト&アナリスト

Analyst

Rachel Meighan-Mantha

Analyst, Principal Analyst
Rachel Meighan-Mantha

Rachel specializes in

  • Oncology
  • Clinical Trials

+22 year(s) experience

Analyst

Amanda Micklus

Analyst, Principal Analyst

Connecticut

Amanda Micklus

Amanda specializes in

  • Oncology
  • Business development and licensing
  • Commercial Strategy

+18 year(s) experience

Management

Michael Hay

Management, Head of Intelligence Products
Michael Hay

Michael specializes in

  • Business Development & Licensing
  • Commercial Strategy

+18 year(s) experience

製品説明を兼ねた無料デモ&お問い合わせ

専任スタッフによる詳しい説明を兼ねた無料デモンストレーションを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

または下記のフォームよりご連絡下さい。

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。